Healthequity Historical Cash Flow

HQY
 Stock
  

USD 60.96  2.13  3.62%   

Analysis of Healthequity cash flow over time is an excellent tool to project Healthequity future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Cash Flow from Financing of 328.7 M or Net Cash Flow Investment Acquisitions and Disposals of 2.3 M as it is a great indicator of Healthequity ability to facilitate future growth, repay debt on time or pay out dividends.Financial Statement Analysis is way more than just reviewing and evaluating Healthequity prevailing accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Healthequity is a good buy for the upcoming year.
Please check Risk vs Return Analysis.
  
Refresh
Share

About Healthequity Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Healthequity balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Healthequity's non-liquid assets can be easily converted into cash.

Healthequity Cash Flow Chart

Healthequity Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Healthequity Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
Healthequity Depreciation Amortization and Accretion is fairly stable at the moment as compared to the past year. Healthequity reported Depreciation Amortization and Accretion of 137.19 Million in 2021. Issuance Purchase of Equity Shares is likely to rise to about 503.2 M in 2022, whereas Capital Expenditure is likely to drop (73.5 M) in 2022.

Issuance Purchase of Equity Shares

A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from common equity changes. Includes additional capital contributions from share issuances and exercise of stock options; and outflow from share repurchases.

Net Cash Flow from Financing

A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from financing activities; from continuing and discontinued operations. Principal components of financing cash flow are: issuance (purchase) of equity shares; issuance (repayment) of debt securities; and payment of dividends & other cash distributions.

Net Cash Flow from Investing

A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from investing activities; from continuing and discontinued operations. Principal components of investing cash flow are: capital (expenditure) disposal of equipment Capital Expenditure; business (acquisitions) disposition Net Cash Flow Business Acquisitions and Disposals and investment (acquisition) disposal Net Cash Flow Investment Acquisitions and Disposals.

Net Cash Flow from Operations

A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from operating activities; from continuing and discontinued operations.
Most accounts from Healthequity cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Healthequity current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Risk vs Return Analysis.Healthequity Depreciation Amortization and Accretion is fairly stable at the moment as compared to the past year. Healthequity reported Depreciation Amortization and Accretion of 137.19 Million in 2021. Issuance Purchase of Equity Shares is likely to rise to about 503.2 M in 2022, whereas Capital Expenditure is likely to drop (73.5 M) in 2022.
 2019 2020 2021 2022 (projected)
Share Based Compensation39.84 M42.86 M52.75 M56.91 M
Net Cash Flow from Operations105.01 M181.62 M141 M117.03 M

Healthequity cash flow statement Correlations

Healthequity Account Relationship Matchups

Healthequity cash flow statement Accounts

201720182019202020212022 (projected)
Capital Expenditure(15.84 M)(13.85 M)(32.94 M)(64.59 M)(71.62 M)(73.5 M)
Depreciation Amortization and Accretion15.95 M18.18 M55.35 M115.9 M137.19 M148.02 M
Net Cash Flow or Change in Cash and Cash Equivalents59.52 M162 M(169.75 M)137.08 M(103.39 M)(106.11 M)
Issuance Purchase of Equity Shares14.56 M22.93 M469.84 M295.35 M466.39 M503.21 M
Net Cash Flow from Financing14.56 M22.93 M1.47 B52.42 M394.86 M328.74 M
Net Cash Flow from Investing(36.75 M)25.65 M(1.74 B)(96.96 M)(639.25 M)(656.07 M)
Net Cash Flow Investment Acquisitions and Disposals(483 K)40.69 M(53.84 M)2.37 M2.13 M2.3 M
Net Cash Flow from Operations81.7 M113.42 M105.01 M181.62 M141 M117.03 M
Share Based Compensation14.31 M21.06 M39.84 M42.86 M52.75 M56.91 M

Healthequity Investors Sentiment

The influence of Healthequity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Healthequity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Healthequity's public news can be used to forecast risks associated with investment in Healthequity. The trend in average sentiment can be used to explain how an investor holding Healthequity can time the market purely based on public headlines and social activities around Healthequity. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Healthequity's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Healthequity's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Healthequity's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Healthequity.

Healthequity Implied Volatility

    
  39.51  
Healthequity's implied volatility exposes the market's sentiment of Healthequity stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Healthequity's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Healthequity stock will not fluctuate a lot when Healthequity's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Healthequity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Healthequity's short interest history, or implied volatility extrapolated from Healthequity options trading.

Current Sentiment - HQY

Healthequity Investor Sentiment

Greater number of Macroaxis users are currently bullish on Healthequity. What is your judgment towards investing in Healthequity? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
4.9 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.